98 related articles for article (PubMed ID: 8750737)
21. Regulation of NMDA-stimulated [14C]GABA and [3H]acetylcholine release by striatal glutamate and dopamine receptors.
Hanania T; Johnson KM
Brain Res; 1999 Oct; 844(1-2):106-17. PubMed ID: 10536266
[TBL] [Abstract][Full Text] [Related]
22. Inhibition by sigma receptor ligand, MS-377, of N-methyl- D-aspartate-induced currents in dopamine neurons of the rat ventral tegmental area.
Yamazaki Y; Ishioka M; Matsubayashi H; Amano T; Sasa M
Psychopharmacology (Berl); 2002 Apr; 161(1):64-9. PubMed ID: 11967632
[TBL] [Abstract][Full Text] [Related]
23. Potent sigma1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine modulates basal and N-methyl-D-aspartate-evoked nitric oxide production in vivo.
Bhardwaj A; Sawada M; London ED; Koehler RC; Traystman RJ; Kirsch JR
Stroke; 1998 Nov; 29(11):2404-10; discussion 2411. PubMed ID: 9804655
[TBL] [Abstract][Full Text] [Related]
24. Functional and binding properties of sigma receptors in rat cerebellum.
Gonzalez-Alvear GM; Thompson-Montgomery D; Deben SE; Werling LL
J Neurochem; 1995 Dec; 65(6):2509-16. PubMed ID: 7595545
[TBL] [Abstract][Full Text] [Related]
25. Sigma(2)-receptor regulation of dopamine transporter via activation of protein kinase C.
Derbez AE; Mody RM; Werling LL
J Pharmacol Exp Ther; 2002 Apr; 301(1):306-14. PubMed ID: 11907188
[TBL] [Abstract][Full Text] [Related]
26. N-alkyl substituted analogs of the sigma receptor ligand BD1008 and traditional sigma receptor ligands affect cocaine-induced convulsions and lethality in mice.
Matsumoto RR; McCracken KA; Pouw B; Miller J; Bowen WD; Williams W; De Costa BR
Eur J Pharmacol; 2001 Jan; 411(3):261-73. PubMed ID: 11164383
[TBL] [Abstract][Full Text] [Related]
27. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
Schoffelmeer AN; Hogenboom F; Mulder AH
Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptors.
Bowen WD; Walker JM; de Costa BR; Wu R; Tolentino PJ; Finn D; Rothman RB; Rice KC
J Pharmacol Exp Ther; 1992 Jul; 262(1):32-40. PubMed ID: 1320690
[TBL] [Abstract][Full Text] [Related]
29. The effect of ibogaine on Sigma- and NMDA-receptor-mediated release of [3H]dopamine.
Sershen H; Hashim A; Lajtha A
Brain Res Bull; 1996; 40(1):63-7. PubMed ID: 8722755
[TBL] [Abstract][Full Text] [Related]
30. Effects of low and high doses of selective sigma ligands: further evidence suggesting the existence of different subtypes of sigma receptors.
Bergeron R; Debonnel G
Psychopharmacology (Berl); 1997 Feb; 129(3):215-24. PubMed ID: 9084059
[TBL] [Abstract][Full Text] [Related]
31. Distinct modulatory roles of sigma receptor subtypes on glutamatergic responses in the dorsal hippocampus.
Bermack JE; Debonnel G
Synapse; 2005 Jan; 55(1):37-44. PubMed ID: 15499608
[TBL] [Abstract][Full Text] [Related]
32. SH-SY5Y cells as a model for sigma receptor regulation of potassium-stimulated dopamine release.
Ault DT; Werling LL
Brain Res; 2000 Sep; 877(2):354-60. PubMed ID: 10986350
[TBL] [Abstract][Full Text] [Related]
33. Modulation of ethanol-induced inhibition of N-methyl-D-aspartate-stimulated neurotransmitter release by glycine.
Woodward JJ; Brown L; Gonzales RA
Alcohol Alcohol Suppl; 1991; 1():177-80. PubMed ID: 1845534
[TBL] [Abstract][Full Text] [Related]
34. Modulation of the neuronal response to N-methyl-D-aspartate by selective sigma2 ligands.
Couture S; Debonnel G
Synapse; 1998 May; 29(1):62-71. PubMed ID: 9552175
[TBL] [Abstract][Full Text] [Related]
35. Regulation of [3H]dopamine release from guinea pig striatum by NMDA receptor/channel activators and inhibitors.
Werling LL; Jacocks HM; McMahon PN
J Pharmacol Exp Ther; 1990 Oct; 255(1):40-5. PubMed ID: 1698972
[TBL] [Abstract][Full Text] [Related]
36. Cooperative contributions of cholinergic and NMDA receptors in the presynaptic control of dopamine release from synaptosomes of the rat striatum.
Chéramy A; Godeheu G; L'Hirondel M; Glowinski J
J Pharmacol Exp Ther; 1996 Feb; 276(2):616-25. PubMed ID: 8632329
[TBL] [Abstract][Full Text] [Related]
37. Effects of sigma receptor ligands on the extracellular concentration of dopamine in the striatum and prefrontal cortex of the rat.
Gudelsky GA
Eur J Pharmacol; 1995 Nov; 286(3):223-8. PubMed ID: 8608783
[TBL] [Abstract][Full Text] [Related]
38. Trishomocubanes: novel sigma-receptor ligands modulate amphetamine-stimulated [3H]dopamine release.
Liu X; Nuwayhid S; Christie MJ; Kassiou M; Werling LL
Eur J Pharmacol; 2001 Jun; 422(1-3):39-45. PubMed ID: 11430911
[TBL] [Abstract][Full Text] [Related]
39. The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin.
Monnet FP; Debonnel G; Bergeron R; Gronier B; de Montigny C
Br J Pharmacol; 1994 Jun; 112(2):709-15. PubMed ID: 8075892
[TBL] [Abstract][Full Text] [Related]
40. Effect of short-term and long-term treatments with sigma ligands on the N-methyl-D-aspartate response in the CA3 region of the rat dorsal hippocampus.
Bergeron R; de Montigny C; Debonnel G
Br J Pharmacol; 1997 Apr; 120(7):1351-9. PubMed ID: 9105712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
